We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Tocilizumab (rch)

Australian Public Assessment Report

AusPAR

AusPAR: Tocilizumab (rch) [PDF, 866.62 KB]

AusPAR: Tocilizumab (rch) [Word, 2.13 MB]

Attachment: Product Information for Tocilizumab (rch) [PDF, 892.1 KB]

Attachment: Product Information for Tocilizumab (rch) [Word, 448.77 KB]

Device/Product Name

Actemra

Active ingredients

Tocilizumab (rch)

AusPAR Date

5 January 2022

Published

6 January 2022

Submission Number

PM-2021-04601-1-2

Submission Type

Extension of indications

Decision

Approved for provisional registration